PL2129391T3 - Metoda diagnostyczna - Google Patents

Metoda diagnostyczna

Info

Publication number
PL2129391T3
PL2129391T3 PL08759218T PL08759218T PL2129391T3 PL 2129391 T3 PL2129391 T3 PL 2129391T3 PL 08759218 T PL08759218 T PL 08759218T PL 08759218 T PL08759218 T PL 08759218T PL 2129391 T3 PL2129391 T3 PL 2129391T3
Authority
PL
Poland
Prior art keywords
hbp
diagnostic method
individual
level
ratio
Prior art date
Application number
PL08759218T
Other languages
English (en)
Inventor
Lars Bjorck
Bertil Christensson
Heiko Herwald
Adam Linder
Per Akesson
Original Assignee
Hansa Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38331957&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2129391(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hansa Medical Ab filed Critical Hansa Medical Ab
Publication of PL2129391T3 publication Critical patent/PL2129391T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
PL08759218T 2007-06-12 2008-06-12 Metoda diagnostyczna PL2129391T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0711327.7A GB0711327D0 (en) 2007-06-12 2007-06-12 Diagnostic method
EP08759218A EP2129391B1 (en) 2007-06-12 2008-06-12 Diagnostic method
PCT/EP2008/004743 WO2008151808A1 (en) 2007-06-12 2008-06-12 Diagnostic method

Publications (1)

Publication Number Publication Date
PL2129391T3 true PL2129391T3 (pl) 2012-09-28

Family

ID=38331957

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08759218T PL2129391T3 (pl) 2007-06-12 2008-06-12 Metoda diagnostyczna

Country Status (16)

Country Link
US (3) US8518648B2 (pl)
EP (1) EP2129391B1 (pl)
JP (1) JP5166522B2 (pl)
KR (1) KR101563997B1 (pl)
CN (2) CN103543271A (pl)
AT (1) ATE548050T1 (pl)
AU (1) AU2008261252B2 (pl)
BR (1) BRPI0812875B8 (pl)
CA (1) CA2690067C (pl)
DK (1) DK2129391T3 (pl)
ES (1) ES2380875T3 (pl)
GB (1) GB0711327D0 (pl)
PL (1) PL2129391T3 (pl)
PT (1) PT2129391E (pl)
SI (1) SI2129391T1 (pl)
WO (1) WO2008151808A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
US20100240049A1 (en) 2009-01-16 2010-09-23 Cepheid Methods of Detecting Cervical Cancer
JP5488885B2 (ja) * 2009-10-28 2014-05-14 国立大学法人 東京大学 感染症の疾患マーカー
GB201016161D0 (en) 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
CA2818887A1 (en) * 2010-11-26 2012-05-31 Immunexpress Pty Ltd Diagnostic and/or screening agents and uses therefor
GB201102108D0 (en) * 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method
US20130084343A1 (en) * 2011-09-16 2013-04-04 Cepheid Methods of detecting sepsis
US10260111B1 (en) 2014-01-20 2019-04-16 Brett Eric Etchebarne Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample
WO2016057945A1 (en) 2014-10-09 2016-04-14 Texas Tech University System Micro-device to detect infection
CN109541235A (zh) * 2018-08-19 2019-03-29 重庆早柒天生物科技股份有限公司 肝素结合蛋白和降钙素原二联检测试剂盒及其制备方法
US20220178932A1 (en) 2019-04-24 2022-06-09 Japanese Foundation For Cancer Research Cancer detection method and detection reagent
CN111208305B (zh) * 2020-02-16 2023-04-25 重庆翼锋生物科技有限公司 Hbp和pct在败血症诊断试剂制备中的用途
CN111951963B (zh) 2020-07-30 2022-09-02 中翰盛泰生物技术股份有限公司 Hbp在covid-19患者的预后风险预警中的应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627262A (en) 1989-07-05 1997-05-06 The Board Of Regents Of The University Of Oklahoma Method and composition for the treatment of septic shock
US5962241A (en) * 1989-07-28 1999-10-05 The University Of Arizona Monoclonal antibody detection of proteins on sperm related to fertility
US5314804A (en) * 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
AU703963B2 (en) * 1994-04-21 1999-04-01 Leukotech A/S Heparin-binding protein for the treatment of sepsis and processes for its preparation
US5976536A (en) 1995-08-09 1999-11-02 Emory University Neisseria mutants, lipooligosaccharides and immunogenic compositions
US5778895A (en) 1997-01-29 1998-07-14 Uab Research Foundation Method of discriminating bacterial from aseptic meningitis
US6303321B1 (en) * 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US7655480B2 (en) 2002-03-08 2010-02-02 The Board Of Regents Of The University Of Oklahoma Method for predicting sepsis or an acute infectious inflammatory response
WO2003076459A1 (en) 2002-03-08 2003-09-18 Heloise, Anne, Pereira, Ph. D. An early detection marker for chronic inflammatory associated diseases
WO2004016653A2 (en) 2002-08-15 2004-02-26 Leukotech A/S Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) or human neutrophil elastase
JP2006515227A (ja) * 2003-02-24 2006-05-25 ジーティーシー バイオセラピューティックス インコーポレイテッド 十字流濾過の方法およびそのための装置
US7191068B2 (en) 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
US20070110804A1 (en) * 2003-06-20 2007-05-17 Royer Biomedical, Inc. Drug polymer complexes
US20070269437A1 (en) 2003-09-19 2007-11-22 Leukotech A/S Pro-Inflammatory and Anti-Inflammatory Antibodies Against the Heparin-Binding Protein (Hbp)
US20050196817A1 (en) 2004-01-20 2005-09-08 Molecular Staging Inc. Biomarkers for sepsis
WO2006113529A2 (en) * 2005-04-15 2006-10-26 Becton, Dickinson And Company Diagnosis of sepsis
EP1931990A4 (en) 2005-10-03 2010-03-10 Biosite Inc METHOD AND COMPOSITIONS FOR DIAGNOSIS AND / OR FORECASTING IN SYSTEMIC INFLAMMATORY RESPONSE SYNDROMES
FR2894675B1 (fr) 2005-12-14 2008-06-27 Assist Publ Hopitaux De Paris Distinction des meningites bacteriennes et virales
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
GB201016161D0 (en) 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
GB201102108D0 (en) 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method

Also Published As

Publication number Publication date
EP2129391A1 (en) 2009-12-09
BRPI0812875A2 (pt) 2014-12-09
US20130252347A1 (en) 2013-09-26
BRPI0812875B1 (pt) 2017-12-05
KR101563997B1 (ko) 2015-10-28
GB0711327D0 (en) 2007-07-25
US20140187503A1 (en) 2014-07-03
JP2010529468A (ja) 2010-08-26
ATE548050T1 (de) 2012-03-15
PT2129391E (pt) 2012-06-06
EP2129391B1 (en) 2012-03-07
BRPI0812875B8 (pt) 2022-07-12
CA2690067C (en) 2023-09-19
WO2008151808A1 (en) 2008-12-18
KR20100021578A (ko) 2010-02-25
AU2008261252B2 (en) 2013-03-14
CN101687023B (zh) 2016-04-20
CN103543271A (zh) 2014-01-29
US8518648B2 (en) 2013-08-27
CN101687023A (zh) 2010-03-31
US9784741B2 (en) 2017-10-10
AU2008261252A1 (en) 2008-12-18
US20100305185A1 (en) 2010-12-02
DK2129391T3 (da) 2012-06-11
ES2380875T3 (es) 2012-05-21
CA2690067A1 (en) 2008-12-18
JP5166522B2 (ja) 2013-03-21
SI2129391T1 (sl) 2012-07-31

Similar Documents

Publication Publication Date Title
GB0711327D0 (en) Diagnostic method
TW200942466A (en) Devices and methods for performing inspections, repairs, and/or other operations within vessels
WO2013154826A3 (en) Methods for diagnosing impending diarrhea
WO2006119479A3 (en) Determining website reputations using automatic testing
UA104459C2 (uk) Антитіла проти fgfr3 і способи їх застосування
EA200971131A1 (ru) Биомаркеры для прогнозирования чувствительности или отсутствия чувствительности к анти-фно агентам
MX349787B (es) Formas de dosis oral que incluyen un agente antiplaqueta y un inhibidor de ácido.
WO2011047087A3 (en) Protein detection via nanoreporters
WO2008073462A8 (en) Computational methods and systems associated with nutraceutical related assays
MX353984B (es) Anticuerpos multi-especificos.
WO2010020884A3 (en) Recommendation generator and method for determining affinities to participate in a venture exchange
WO2008036317A3 (en) Systems and methods for pathogen detection and response
MX2022013625A (es) Metodo para evaluar los efectos de una composicion que comprende microorganismos en la microbiota intestinal.
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
WO2015070001A3 (en) Compositions and methods for detecting and/or treating inflammation
BR112012029919A2 (pt) processo para a preparação de 8-alcóxi[1,2,4]triazolo[1,5-c]pirimidin-2-aminas substituídas em 5
EA201171178A1 (ru) Устройство и способ для определения и количественного анализа аналитов, в частности, микотоксинов
BRPI0912249A2 (pt) método de prevenir o desenvolvimento de artrite reumatoide em indivíduos com artrite não diferenciada.
NO20084320L (no) Antistoffer mot EGFL7 og fremgangsmater for anvendelse av disse
GB201102108D0 (en) Diagnostic method
WO2007028088A3 (en) Methods for enhancing the dewaterability of sludge with alpha-amylase treatment
NZ601648A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
TW200700726A (en) Autoantibody detection for cancer diagnostics
EA200970074A1 (ru) Химический способ создания давления
WO2007019276A3 (en) Quantitative detection of lead in water